Taylor Brenton 4
4 · Sight Sciences, Inc. · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
Sight Sciences (SGHT) EVP Taylor Brenton Sells 2,869 Shares
What Happened
- Taylor Brenton, EVP of Operations & R&D at Sight Sciences (SGHT), sold 2,869 shares of common stock in an open-market/private sale on April 1, 2026. The weighted average sale price was $3.70 per share for aggregate proceeds of approximately $10,615. The sale was made to cover the reporting person's tax liability in connection with the vesting of restricted stock units (RSUs).
Key Details
- Transaction date: 2026-04-01; filing date (Form 4): 2026-04-03 (timely filing).
- Sale type/code: S (sale); reason: tax withholding to cover RSU vesting (footnote F1).
- Price: weighted average $3.70; shares sold in multiple transactions at prices ranging $3.63–$3.85 (footnote F2).
- Holdings after transaction: beneficial ownership includes 31,631 shares of Common Stock and 236,176 RSUs that have not yet vested (footnote F3).
- The reporting person will provide details of how many shares were sold at each price within the stated range upon request (per F2).
Context
- This was a routine tax-withholding sale tied to RSU vesting rather than a discretionary investment sale; such transactions are common and do not necessarily indicate a change in the insider’s view of the company.
Insider Transaction Report
Form 4
Taylor Brenton
EVP, Operations & R&D
Transactions
- Sale
Common Stock
[F1][F2][F3]2026-04-01$3.70/sh−2,869$10,615→ 267,807 total
Footnotes (3)
- [F1]Reflects shares of the Issuer's common stock, par value $0.001 per share ("Common Stock"), sold to cover the Reporting Person's tax liability in connection with the vesting of restricted stock units ("RSUs").
- [F2]Reflects the weighted average price at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $3.63 to $3.85, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Includes (i) 31,631 shares of Common Stock, and (ii) 236,176 shares of Common Stock which shall be acquired upon the vesting and settlement of RSUs that have not yet vested.
Signature
/s/Jeremy Hayden, Attorney-in-Fact for Brenton Taylor|2026-04-03